电子烟用于戒烟对抑郁和焦虑症状的影响:随机对照试验的二次分析
Anna Rihs1, Anna Schoeni2, Tamara Scharf3
1Institute of Primary Health Care (BIHAM), University of Bern, Switzerland; Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland.
General hospital psychiatry
|January 19, 2025
概括
电子烟作为戒烟辅助剂在6个月的试验中没有显著影响抑郁或焦虑症状. 这项研究发现,电子烟使用者和仅接受心理健康咨询的人之间没有临床相关的差异.
科学领域:
- 成 药物 药物 药物 药物
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 戒烟仍然是一个重大的公共卫生挑战.
- 电子烟 (e-cigarettes) 越来越多地被用作戒烟辅助工具.
- 电子烟在戒烟期间对心理健康的影响需要进一步研究.
研究的目的:
- 为了评估电子烟对抑郁和焦虑症状的影响,在6个月的随访中.
- 为了比较戒烟试验中的心理健康结果,使用电子烟与单独咨询相比.
主要方法:
- 对ESTxENDS随机对照试验 (RCT) 的二次分析.
- 使用患者健康问卷-9 (PHQ-9) 评估抑郁症状,使用一般焦虑障碍-7 (GAD-7) 评估焦虑症状.
- 在6个月的随访期间,接受电子烟的参与者和仅接受咨询的参与者之间的结果进行了比较.
主要成果:
- 913名参与者完成了PHQ-9和884人完成了6个月的GAD-7.
- 平均PHQ-9分数为3.7 (干预) 与4.0 (对照);平均GAD-7分数为4.6 (干预) 与4.6 (对照).
- 多变量分析显示,对PHQ-9或GAD-7得分没有临床相关的干预效应.
结论:
- 电子烟用于戒烟的分发,除了标准咨询,还没有对抑郁或焦虑症状产生临床相关的影响.
- 研究结果表明,电子烟对于试图戒烟的吸烟者来说,短期内不会对心理健康症状产生不利影响.
- 进一步的研究可能会探索长期的心理健康影响和特定的用户子组.
更多相关视频
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
11.4K
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
8.3K
相关概念视频
Stimulants
157
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
157
Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
294
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
294
